Synthesis, processing and secretion of surfactant proteins B and C  by Weaver, Timothy E.
Review
Synthesis, processing and secretion of surfactant proteins B and C
Timothy E. Weaver *
Children’s Hospital Medical Center, Division of Pulmonary Biology, 3333 Burnet Avenue, Cincinnati, OH 45229-3039, USA
Received 3 March 1998; received in revised form 4 May 1998; accepted 4 May 1998
Abstract
Two small, hydrophobic peptides, surfactant protein (SP)-B and SP-C, play important roles in the generation and
maintenance of a surface active film in the alveolus. Isolation and characterization of the cDNAs encoding SP-B and SP-C
indicate that both peptides are synthesized as larger proproteins which are proteolytically processed to peptides with Mr
approx. 8000 and 4000, respectively. The biosynthetic pathway leading to generation and secretion of the biophysically active
mature SP-B and SP-C peptides is reviewed. ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
The ¢rst protein speci¢cally associated with surfac-
tant phospholipids was identi¢ed by King et al. in
1973 [1] and subsequently named surfactant protein
A (SP-A) [2]. Identi¢cation of the small hydrophobic
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peptides, SP-B and SP-C, lagged behind SP-A be-
cause of their avid association with lipids, di⁄culty
in resolving them in SDS^PAGE gels and their lack
of staining by Coomassie blue. The ¢rst evidence for
surfactant-associated hydrophobic peptides came
from a study by Phizackerly et al. [3] who detected
peptides of Mrv11 500^16 500 in organic solvent ex-
tracts of lamellar bodies. Subsequently a number of
groups identi¢ed SP-B, Mr approx. 8000, which was
detected as a multimer (dimer in most species) under
non-reducing electrophoretic conditions, and SP-C,
Mr approx. 4000. Amino acid sequence analyses of
SP-B and SP-C and the successful generation of anti-
serum against SP-B led to the identi¢cation of cDNA
clones encoding these two peptides [4^8]. The de-
duced amino acid sequence of these cDNA clones
indicated that both SP-B and SP-C were contained
within the sequence of larger propeptides. The bio-
synthetic pathway leading to generation of mature
SP-B and SP-C is reviewed.
2. Cell-speci¢c expression of SP-B and SP-C
SP-B expression is restricted to Clara cells and
alveolar type II cells of the respiratory epithelium.
SP-C is expressed only in type II cells; identi¢cation
of the human 3.7 kb SP-C promoter has provided an
extraordinarily valuable tool for targeting expression
of a wide variety of proteins to the distal respiratory
epithelium of transgenic mice. Although SP-C and
SP-B expression in type II cells is clearly associated
with the biosynthesis of pulmonary surfactant, the
function of SP-B in Clara cells remains unclear.
Ablation of SP-B expression in type II cells but not
Clara cells results in neonatal lethality, similar to
SP-B knockout mice, suggesting that the Clara cell
does not contribute SP-B to the alveolar surfactant
pool (Weaver et al., unpublished results). Expression
of SP-B is dramatically increased in Clara cells and
decreased in type II cells during hyperoxic lung in-
jury [9,10]; however, the functional signi¢cance of
altered SP-B expression is not known.
3. Biosynthesis of SP-B and SP-C proproteins
The primary translation products of human SP-B
in both Clara cells and type II cells is a preproprotein
of 381 amino acids (Fig. 1). A signal peptide of
23 amino acids, located at the NH2 terminus of the
proprotein, mediates translocation of SP-B into the
lumen of the endoplasmic reticulum. Cotranslational
cleavage of the signal peptide yields a proprotein
consisting of an NH2-terminal propeptide (residues
24^200), the 79 amino acid mature peptide (residues
201^279), and a COOH-terminal propeptide (resi-
dues 280^381). The COOH-terminal propeptide is
glycosylated on asparagine at position 311 but the
function of this post-translational modi¢cation is
not known. Inhibition of asparagine-linked glycosy-
lation by tunicamycin or deletion of the entire
102 amino acid COOH-terminal propeptide does
not perturb intracellular tra⁄cking of the propro-
tein; in contrast, deletion of the 177 amino acid
NH2-terminal propeptide results in accumulation of
SP-B within the endoplasmic reticulum, consistent
with the hypothesis that this propeptide is an intra-
molecular chaperone for the hydrophobic mature
peptide [11].
The overall organization of the 197 amino acid
Fig. 1. Processing and association of SP-B with phospholipids.
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human SP-C proprotein is similar to SP-B in that the
35 amino acid mature peptide (residues 24^58) is
£anked by an NH2-terminal propeptide (residues 1^
23) and a COOH-terminal propeptide (residues 59^
197) (Fig. 2); alternative splicing of the SP-C pri-
mary transcript results in an RNA encoding a pro-
protein of 191 amino acids, although there is no
evidence to date that this transcript is actually trans-
lated. The proprotein lacks a typical signal peptide
and is only partly translocated through the mem-
brane of the endoplasmic reticulum resulting in an
integral membrane con¢guration. The topology of
the newly synthesized proprotein within the mem-
brane is not clear with reports of type II and type
III orientation [12,13]. The experimental data to date
are most consistent with a type II orientation for
SP-C, in which the NH2-terminus of the proprotein
is located in the cytoplasm and the COOH-terminus
Fig. 2. Processing and association of SP-C with a bilayer membrane.
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is located in the lumen of the endoplasmic reticulum.
Residues 11 and 12 of the native peptide (lysine and
arginine, respectively) may constitute a stop-transfer
signal which prevents translocation of the entire pro-
protein into the lumen of the endoplasmic reticulum.
The proprotein is anchored within the membrane by
residues 13^35 of the mature peptide, and this region
has been shown to form a rigid K-helix characteristic
of most transmembrane domains [14^16]. The mem-
brane spanning domain of SP-C is unique in several
respects: (1) secondary structure analyses (Chou^
Fasman algorithm) predict primarily L-sheet confor-
mation rather than the experimentally con¢rmed
K-helical conformation; (2) valine is overrepresented
comprising greater than 50% of the amino acids in
the membrane spanning domain of SP-C although
the functional signi¢cance of valine enrichment in
this domain is not clear; and (3) the transmembrane
domain of SP-C comprises the major part (63%) of
the biologically active mature peptide. The extra-
membrane domain of the mature peptide (residues
1^12) is located in the cytoplasm (assuming a type
II membrane orientation) and is signi¢cantly more
polar than the extraordinarily hydrophobic trans-
membrane domain; however, the overall hydrophi-
licity of this domain is decreased by palmitoylation
of cysteine residues at positions 5 and 6 [17]. The
function of SP-C palmitoylation, which presumably
occurs during transit from the endoplasmic reticulum
to the Golgi, is not known. Deletion analyses of the
SP-C proprotein suggest that the C-terminal propep-
tide, in particular the last 22 amino acids, is impor-
tant for intracellular tra⁄cking of SP-C [18].
4. Intracellular tra⁄cking of SP-B and SP-C
proproteins
Following translocation into the endoplasmic re-
ticulum, proteins are transported by bulk £ow to
the Golgi and from there to plasma membrane for
secretion. This pathway is referred to as the consti-
tutive (default) secretory pathway. While all cells
contain the constitutive secretory pathway, endocrine
and exocrine cells (such as the type II cell) contain a
second secretory pathway in which certain proteins
(e.g., SP-B and SP-C) are concentrated into secretory
granules, referred to as lamellar bodies in type II
cells, which are released in response to external stim-
uli. This pathway is referred to as the regulated se-
cretory pathway (for review see Ref. [19]). Transport
of proteins to the secretory granule requires recogni-
tion of sorting signals encoded within the protein
structure in order to divert them from the constitu-
tive secretory pathway. It is generally accepted that
sorting of secretory proteins occurs in the trans-Gol-
gi network.
The sorting of SP-B to the regulated secretory
pathway has been studied by expressing deletion con-
structs of the SP-B proprotein in PC-12 cells, a rat
pheochromocytoma cell line with a well-character-
ized regulated secretory pathway. These studies dem-
onstrated that the NH2-terminal propeptide but not
the C-terminal propeptide was required for sorting of
SP-B to secretory granules [20]; the NH2-terminal
propeptide alone was not sorted to secretory gran-
ules in the absence of the mature peptide suggesting
that the sorting epitope(s) spanned both peptide do-
mains. These results were con¢rmed in vivo by dem-
onstrating that an SP-B construct consisting of the
signal peptide, NH2-terminal propeptide and mature
peptide (SP-Bvc) was appropriately sorted, processed
and secreted into the airway of transgenic mice [20].
The structure of the sorting epitope and the putative
receptor with which it interacts have not been iden-
ti¢ed.
Deletion analyses directed toward identifying the
sorting epitope for SP-C have not yet been per-
formed. The sorting of SP-C to the regulated secre-
tory pathway of type II epithelial cells is likely sim-
ilar to sorting of integral membrane proteins, in
particular lysosomal membrane proteins. Several ly-
sosomal membrane proteins such as Lamp-1/lgp 120
[21] and Limp-1/CD63 [22] have been detected in the
membrane of the lamellar body, suggesting that sim-
ilar sorting motifs may be used by these two organ-
elles; this hypothesis is also supported by the obser-
vation that the lamellar body also contains soluble
lysosomal enzymes [23]. Lysosomal membrane pro-
teins have very short cytoplasmic domains (11^25
amino acids) which contain amino acids that interact
with cytosolic proteins to direct the membrane pro-
tein to the lysosome (for review see Ref. [24]). The
predicted cytoplasmic domain of SP-C, consisting of
the N-terminal propeptide and the extramembrane
domain of the mature peptide, is also quite short
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(33 amino acids) and may encode a sorting epitope,
although this hypothesis remains to be tested.
5. Processing of SP-B and SP-C proproteins
The SP-B and SP-C proproteins are transported
from the trans-Golgi network to the multivesicular
body. Proteolytic processing of the proproteins to
their respective mature peptides has been shown to
occur in an acidic compartment distal to the Golgi,
consistent with processing in the multivesicular body
[25,26]. Direct evidence for this hypothesis was pro-
vided by immunogold labeling of ultrathin cryosec-
tions of rat lung which demonstrated that the only
subcellular compartment which contained both the
proproteins and the mature peptides was the multi-
vesicular body [13,22].
The mature SP-B peptide is generated by sequen-
tial cleavage of the NH2-terminal and COOH-termi-
nal propeptides [27,28]. Sulfhydryl-dependent oligo-
merization of the mature peptide likely occurs
immediately after or during processing since the ma-
ture peptide is mostly detected as an oligomer (pre-
dominantly dimer), and proprotein oligomers are
never detected. Given the hydrophobicity of the ma-
ture peptide, it is also likely that association of SP-B
with surfactant phospholipids is closely linked to
proprotein processing. As many as four amphipathic
helices (Fig. 1) may mediate interaction of SP-B with
the headgroups and acyl chains of phospholipid ¢lms
[29,30]. Newly processed SP-B may associate with the
internal vesicles of the multivesicular body and pro-
mote vesicle fusion which, in turn, may facilitate for-
mation of membrane lamellae. This hypothesis is
supported by several lines of evidence: SP-B has
been shown to promote vesicle fusion in vitro [31];
membrane lamellae are occasionally detected in mul-
tivesicular bodies; and type II cells of SP-B knockout
mice contain numerous multivesicular bodies but no
mature lamellar bodies, suggesting that formation of
membrane lamellae is SP-B-dependent [32]. How-
ever, although these observations are compelling, di-
rect evidence for this hypothesis is still lacking.
The COOH-terminal propeptide, released from the
proprotein by proteolytic cleavage, may also play an
important role in lamellar body homeostasis. Trans-
genic mice in which endogenous SP-B expression has
been completely replaced by SP-Bvc (and conse-
quently do not express the COOH-terminal propep-
tide) have signi¢cantly increased tissue surfactant
pool size and dramatically enlarged lamellar bodies
[33]. These results suggest that the COOH-terminal
propeptide may be an important determinant of in-
tracellular surfactant pool size. The mechanism
underlying this potential function of SP-B is not
clear.
Processing of the SP-C proprotein di¡ers from
SP-B in that the COOH-terminal propeptide is ¢rst
removed by stepwise cleavage followed by cleavage
of the NH2-terminal propeptide [13,34]. The en-
zyme(s) responsible for processing of the SP-C and
SP-B proproteins have not been identi¢ed, and it is
not known if distinct enzymes are required for proc-
essing of each proprotein. Processing of the SP-C
proprotein is linked to SP-B expression, as indicated
by the phenotype of SP-B de¢cient human infants
and mice [32,35,36] : in the absence of SP-B expres-
sion the SP-C proprotein is incompletely processed,
resulting in accumulation of SP-C peptide with Mr of
approximately 12 000 [37]. The mechanism whereby
SP-B expression in£uences SP-C processing remains
unclear.
6. Secretion of SP-B and SP-C
The multivesicular body delivers SP-B and SP-C
with their associated phospholipids to the lamellar
body, the intracellular storage form of surfactant.
The formation of characteristic tightly packed con-
centric membrane sheets (lamellae) is likely facili-
tated by the high concentration of calcium in this
compartment which may reduce charge repulsion re-
lated to anionic phospholipid headgroups [38]. The
cationic SP-B peptide may also contribute to mem-
brane stabilization by decreasing charge repulsion
and/or the formation of homodimers with SP-B in
adjacent membranes (Fig. 1); likewise, SP-C may
promote membrane packing via interaction of palmi-
tate moieties on cysteines 5 and 6 with the acyl
chains of adjacent bilayer membranes (Fig. 2).
Each of these hypotheses remains to be tested.
It is now well established that type II epithelial
cells in culture secrete lamellar bodies in response
to a variety of secretagogues [39]: The relevant phys-
BBADIS 61770 30-10-98
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iologic stimuli for secretion in vivo and the contribu-
tion of basal (i.e. non-stimulated) secretion to the
alveolar surfactant pool are less certain. The secre-
tion kinetics for SP-B and phosphatidylcholine are
similar [40], consistent with the hypothesis that these
components are secreted together as part of the fully
assembled surfactant complex. Although it is clear
that SP-C is also secreted by the type II cell, the
mechanism underlying secretion of this integral
membrane protein is not known. Membrane proteins
in the secretory pathway are located in the limiting
membrane of vesicular intermediates and are incor-
porated into the plasma membrane during exocyto-
sis. SP-C is unique in that it is secreted rather than
retained at the cell surface. The results of immuno-
gold labeling studies indicate that SP-C is detected in
both the limiting membrane of the multivesicular
body and on the internal vesicles of that organelle
[13] ; in contrast, SP-C is only detected within the
lumen of the lamellar body, consistent with the hy-
pothesis that translocation from the limiting mem-
brane to the lumen occurs within the multivesicular
body. The mechanism underlying translocation may
be similar to that involved in endocytosis and degra-
dation of the EGF receptor: a sequence motif within
the cytoplasmic domain of the EGF receptor medi-
ates internalization and entry into the endosomal
compartment; a distinct motif drives inward vesicu-
lation of the limiting membrane resulting in accumu-
lation of vesicles containing the receptor within the
lumen of the endosome (i.e. multivesicular endo-
some) [41,42]. This model would account for the de-
tection of SP-C on internal vesicles of multivesicular
bodies and predicts that the NH2-and/or COOH-ter-
minal propeptide encodes a motif that directs inward
vesiculation of the proprotein.
7. Future directions
Most of the research on SP-B and SP-C has been
directed toward understanding the extracellular func-
tions of these peptides, in particular their ability to
promote the formation of a surface ¢lm at the alveo-
lar air^liquid interface. The phenotype of the SP-B
knockout mouse strongly suggests that SP-B also
plays a critical role in assembly of the surfactant
complex; the SP-C knockout mouse, which has not
yet been generated, may be similarly instructive. The
availability of the knockout mouse model in combi-
nation with the speci¢city of the SP-C promoter pro-
vides a powerful experimental strategy to assess both
the intracellular and extracellular functions of the
hydrophobic peptides in vivo. This approach in-
volves selective mutation of the SP-B or SP-C
cDNA which is then cloned under control of the
SP-C promoter. The construct is microinjected into
fertilized mouse eggs and transgenic lines established.
Mice which express the transgene are subsequently
crossed with hemizygous mice (mice in which one
SP-B or SP-C allele has been disrupted and does
not encode a functional protein) for two generations
in order to achieve expression of the transgene in a
null background, i.e., in a small number of o¡spring,
expression of mutated SP-B or SP-C will completely
replace endogenous peptide expression. The patho-
physiology associated with the mutation or deletion
can then be assessed in the context of the whole
animal and the impact on surfactant homeostasis
evaluated. This experimental approach, although
time-consuming and expensive, should provide val-
uable new insight into the function of the hydropho-
bic peptides and the structural bases for these func-
tions.
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